Forensic Science Ireland’s (FSI) latest report reveals cannabis and its related products make up 42% of analyzed drug cases in 2023. The report highlights the increasing prevalence of semi-synthetic cannabinoids like HHC, which pose significant public health risks due to their unknown long-term effects and potential for contamination. This concerning trend underscores the need for tighter regulations and public awareness about the dangers of these legal yet potentially harmful substances.
Results for: Drug Market
The global market for Friedreich’s Ataxia drugs is projected to experience significant growth, reaching a value of US$ 3.49 billion by 2034. This growth is driven by increased investments in disease-modifying treatments and gene therapy, as well as supportive initiatives from governments and non-profit organizations. The market is expected to be dominated by North America, with a projected market share of 36.7% by 2034.